GT Biopharma (GTBP) Prepaid Assets (2010 - 2026)
GT Biopharma (GTBP) posted quarterly Prepaid Assets of $409000.0 for Q1 2026, up 104.5% year-over-year from $200000.0 in Q1 2025, and down 27.87% quarter-over-quarter from $567000.0 in Q4 2025.
GT Biopharma (GTBP) Prepaid Assets (2010 - 2026) Analysis & Trends
GT Biopharma (GTBP) has reported Prepaid Assets for 15 consecutive years, with $409000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 104.5% year-over-year to $409000.0; the TTM figure through Mar 2026 stood at $409000.0 (up 104.5% YoY), while the FY2025 annual figure was $567000.0, up 201.6% from the prior year.
- Prepaid Assets eased to $409000.0 in Q1 2026 per GTBP's latest filing, from $567000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $1.0 million in Q2 2025 and bottomed at $38000.0 in Q1 2023.
- Historically, Prepaid Assets has averaged $293625.0 across 5 years, with a median of $194000.0 in 2024.
- Annual changes were most pronounced in 2023 — Prepaid Assets slumped 91.61% — and 2024, when it soared 552.63%.
- GT Biopharma's Prepaid Assets stood at $54000.0 in 2022, then surged by 55.56% to $84000.0 in 2023, then surged by 123.81% to $188000.0 in 2024, then jumped by 201.6% to $567000.0 in 2025, then declined by 27.87% to $409000.0 in 2026.
- Business Quant data shows GTBP's Prepaid Assets at $409000.0 in Q1 2026, $567000.0 in Q4 2025, and $940000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GT Biopharma | 8.64 Mn | 8.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 409,000.00 |
| Dec 31, 2025 | 567,000.00 |
| Sep 30, 2025 | 940,000.00 |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 188,000.00 |
| Sep 30, 2024 | 248,000.00 |
| Mar 31, 2024 | 78,000.00 |
| Dec 31, 2023 | 84,000.00 |
| Sep 30, 2023 | 38,000.00 |
| Jun 30, 2023 | 48,000.00 |
| Mar 31, 2023 | 38,000.00 |
| Dec 31, 2022 | 54,000.00 |
| Sep 30, 2022 | 88,000.00 |
| Jun 30, 2022 | 222,000.00 |
| Mar 31, 2022 | 453,000.00 |
| Dec 31, 2021 | 190,000.00 |
| Sep 30, 2021 | 85,000.00 |
| Jun 30, 2021 | 62,000.00 |
| Mar 31, 2021 | 88,000.00 |